“I have so many good things to say about Hadassah,” says Hannah, mother of a newborn who, though missing one of the chambers of his heart, was saved by cardiac specialists at the Hadassah Medical Center. “The medical care the baby received was outstanding,” she says, “but it was the human touch that made it so special. I cannot imagine having a better team.”
The patient was 30 years old and he was dying. His liver—scarred beyond repair by cirrhosis that followed a hepatitis B infection 18 years earlier—was scarcely functioning.
Among the innovative explorations in cancer treatment at The Hadassah Medical Center’s Sharett Institute of Oncology are a vaccine which boosts a patient’s immune system response to battle recurrence of cancer; identifying tailored therapies for patients based on their genetic background; determining why only some mothers and some daughters who carry the BRCA gene get breast cancer and at different stages of their lives; and how to best support Holocaust survivors who now face cancer.
Hadassah Medical Center Bone Marrow Transplantation Expert Prof. Reuven Or recently helped the Ruby Hall Clinic in Pune, India to open a Bone Marrow Transplantation Department.
Every day miracles take place here at Hadassah. Babies are born. Lives are saved. Bone marrow is transplanted. Shattered bones are reconstructed. Groundbreaking research is developed. In every department, our professionals make miracles happen.
The Hadassah Medical Center’s nursing leadership is reshaping the role of nurses to maximize the many skills nurses bring to the medical team. One chief strategy is empowering nurses with greater autonomy to make decisions to enhance patient care; another is the establishment of a Nursing Research Center to generate hospital-wide clinical research studies.
Researchers at the Hadassah University Medical Center have developed a novel strategy to derive and control differentiation of large quantities of human embryonic stem cells (hESCs), which may hold the key to reversing disorders such as Parkinson’s disease, diabetes, and Age-related Macular Degeneration (AMD).
Research at the Hadassah Medical Center has been bolstered by a new momentum, thanks to the success of Hadasit, its technology transfer company, and the new Biotechnology Park on Hadassah-Ein Kerem’s campus.
Hadasit Bio-Holdings Ltd., the Hadassah Medical Center’s technology transfer company, has announced that two of the leading biotechnology investment groups in Israel have donated $1.5 million each to ProtAb, its wholly owned portfolio company.
A new program has opened in Jerusalem, one that combines the best of Hadassah’s medical school with elite Army training.